Josee Guindon, DVM, PhD of Texas Tech University Health Sciences Center, was named as the recipient for this award, which recognizes dedication, perseverance, and skill in studying and researching the endocannabinoid system.
In early January, Texas Tech University Health Sciences Center (TTUHSC) announced that researcher and associate professor Josee Guindon, DVM, PhD, had been chosen to receive the international William A. Devane Young Investigator Award from the International Cannabinoid Research Society (ICRS). Dr. Guindon will receive the award at the ICRS’s 33rd Annual International Cannabinoid Research Society Symposium June 24–29, 2023 in Toronto, Canada.
“It's quite a diverse field that has been booming extensively and a lot of National Institute of Health (NIH) funding is put toward cannabinoids because of its legalization across many states now,” said Dr. Guindon (1). “Basically, it’s medicinal versus recreational that are the main focus, but a lot of studies now are trying to improve our understanding about the physiological effects of cannabinoids across different disciplines.”
According to TTUHSC’s announcement, three of Dr. Guindon’s most recent peer-reviewed publications demonstrated the role of sex hormones and cannabinoids in pain, in modulating breast and ovarian cancer tumor growth, and how cannabinoids influence ovarian tumor growth (1).
Reference
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.